CHIR Chiron (MM)

Chiron to Release Earnings on Wednesday, April 21, 2004 Conference Call/Webcast to Follow EMERYVILLE, Calif., April 7 /PRNewswire-FirstCall/ -- Chiron Corporation today announced that it will release its first-quarter 2004 financial results on Wednesday, April 21, at 4:00 p.m. EDT. Forty-five minutes later, at 4:45 p.m. EDT, as part of its efforts to ensure full disclosure to all parties, Chiron will webcast an earnings discussion conference call live from Chiron.com. To access either the live call or the one-week archive, please log on to http://www.chiron.com/webcast. Please connect to the website at least 15 minutes prior to the conference call to ensure adequate time to download any necessary software. Alternatively,please call 800-374-0907 from the U.S. or Canada or 706-643-3367 from other locations. Replay is available approximately two hours after the completion of the call through 11:55 p.m. EDT, Wednesday, April 28, 2004. To access the replay, please call 800-642-1687 from the U.S. or Canada or 706-645-9291 from other locations. The conference ID number is 6631837. About Chiron Chiron Corporation, headquartered in Emeryville, California, is a global pharmaceutical company that leverages a diverse business model to develop and commercialize high-value products that make a difference in people's lives. The company has a strategic focus on cancer and infectious disease. Chiron applies its advanced understanding of the biology of cancer and infectious disease to develop products from its platforms in proteins, small molecules and vaccines. The company commercializes its products through three business units: BioPharmaceuticals, Vaccines and Blood Testing. For more information about Chiron, visit the company's website at http://www.chiron.com/. DATASOURCE: Chiron Corporation CONTACT: Chiron Corporate Communications & Investor Relations, media, +1-510-923-6500, or investors, +1-510-923-2300 Web site: http://www.chiron.com/

Copyright